Vimarsana
Biggest News Aggregation in the World

Eric Van Cutsem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Van Cutsem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Van Cutsem Today - Breaking & Trending Today

Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy - Vimarsana News

Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy

LUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023 - Vimarsana News

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for

Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023 - Vimarsana News

Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today...

HMP Global Announces Digestive Cancers Europe (DiCE) as Partner for 25th World Congress on Gastrointestinal Cancer - Vimarsana News

HMP Global Announces Digestive Cancers Europe (DiCE) as Partner for 25th World Congress on Gastrointestinal Cancer

More than 3,000 delegates expected in Barcelona 28 June – 1 July for the leading forum for GI cancer professionals from 95+ countries

Cardiff Oncology Formally Introduces Scientific Advisory Board - Vimarsana News

Cardiff Oncology Formally Introduces Scientific Advisory Board

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...